Long-acting Etonogestrel Microspheres
Description: Orbis Biosciences is developing a 6-month injectable microsphere formulation containing etonogestrel using Orbis Biosciences' patented Precision Particle Fabrication (PPF) technology for achieving uniform particle size.
Product Details
Delivery Method: ,
Duration: 6 months
Regimen:
Active Pharmaceutical Ingredient (API):
Status Details
Began discovery in: 2013
Additional Information
References: Orbis Biosciences website: http://www.orbisbio.com/index.html
Orbis Biosciences website: http://www.orbisbio.com/index.html